ZLDAF

Zelira Therapeutics Ltd, formerly Zelda Therapeutics Ltd, is an Australia-based therapeutic medicinal cannabis company. The company is focused on developing cannabis products for the treatment of a variety of medical conditions. It is focused on human clinical trial programs focused on insomnia, autism and opioid reduction with activities in Australia and the United States. It is also focused on pre-clinical research examining the effect of cannabinoids in breast, brain and pancreatic cancer, as well as research and development of cannabinoids to treat diabetes-associated cognitive decline. It develops treatments based on plant-derived medicinal cannabis products.